Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.
This post has been syndicated from Truthout, where it was published under this address.
Big Pharma Front Groups Muddle Debate Over Drug Prices, Patient Advocates Say Read Post »
The administration is seeking to lower costs by obtaining “most favored nation” status among pharmaceutical companies.
This post has been syndicated from Truthout, where it was published under this address.
Trump’s Executive Order to Lower Drug Costs Has No Clear Enforcement Mechanism Read Post »
One policy advocate described the move as “a total capitulation to the demands of drug corporation lobbyists.”
This post has been syndicated from Truthout, where it was published under this address.
Trump Signs Executive Order Delaying Negotiations for Prescription Drug Prices Read Post »
Find your voice:
